Literature DB >> 28807967

Teeranai Sakulchit, Susanne M Benseler, Ran D Goldman.   

Abstract

Year:  2017        PMID： 28807967      PMCID： PMC5555339     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  18 in total

1.  Effects of anti-inflammatory drugs on intravenous immunoglobulin therapy in the acute phase of Kawasaki disease.

Authors:  Toshimasa Nakada
Journal:  Pediatr Cardiol       Date:  2014-08-27       Impact factor: 1.655

Review 2.  Kawasaki disease.

Authors:  Rosie Scuccimarri
Journal:  Pediatr Clin North Am       Date:  2012-04       Impact factor: 3.278

3.  Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes.

Authors:  Gi Beom Kim; Jeong Jin Yu; Kyung Lim Yoon; Soo In Jeong; Young Hwan Song; Ji Whan Han; Young Mi Hong; Chan Uhng Joo
Journal:  J Pediatr       Date:  2016-12-30       Impact factor: 4.406

4.  Reye's syndrome developing in an infant on treatment of Kawasaki syndrome.

Authors:  Chih-Ming Wei; Huey-Ling Chen; Ping-Ing Lee; Chong-Ming Chen; Chun-Yi Ma; Wuh-Liang Hwu
Journal:  J Paediatr Child Health       Date:  2005 May-Jun       Impact factor: 1.954

5.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

6.  Kawasaki disease with Reye syndrome: report of one case.

Authors:  J H Lee; H Y Hung; F Y Huang
Journal:  Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi       Date:  1992 Jan-Feb

7.  Coronary artery outcomes among children with Kawasaki disease in the United States and Japan.

Authors:  Shohei Ogata; Adriana H Tremoulet; Yuichiro Sato; Kayla Ueda; Chisato Shimizu; Xiaoying Sun; Sonia Jain; Laura Silverstein; Annette L Baker; Noboru Tanaka; Yoshihito Ogihara; Satoshi Ikehara; Shinichi Takatsuki; Naoko Sakamoto; Tohru Kobayashi; Shigeto Fuse; Tomoyo Matsubara; Masahiro Ishii; Tsutomu Saji; Jane W Newburger; Jane C Burns
Journal:  Int J Cardiol       Date:  2013-07-11       Impact factor: 4.164

8.  High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.

Authors:  Ho-Chang Kuo; Mao-Hung Lo; Kai-Sheng Hsieh; Mindy Ming-Huey Guo; Ying-Hsien Huang
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

Review 9.  Epidemiology of Kawasaki disease in Asia, Europe, and the United States.

Authors:  Ritei Uehara; Ermias D Belay
Journal:  J Epidemiol       Date:  2012-02-04       Impact factor: 3.211

10.  The outcome of short-term low-dose aspirin treatment in Kawasaki disease based on inflammatory markers.

Authors:  Jae Won Yoo; Ji Mok Kim; Hong Ryang Kil
Journal:  Korean J Pediatr       Date:  2017-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.